News
Pfizer Options Trading: A Deep Dive into Market Sentiment
22 Apr 24
Options, Markets
European Commission Approves Pfizer's EMBLAVEO For Patients With Multidrug-Resistant Infections And Limited Treatment Options
22 Apr 24
Biotech, Government, News, Regulations, General
Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target
18 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
16 Apr 24
News, Health Care, General
Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target
15 Apr 24
News, Price Target, Reiteration, Analyst Ratings
A Closer Look at Pfizer's Options Market Dynamics
15 Apr 24
Options, Markets
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
11 Apr 24
News, Dividends, Health Care, Price Target, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General
Pfizer Stock Rises on Upbeat RSV Vaccine Trial Data
11 Apr 24
News, Health Care, Markets, Trading Ideas, General
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
10 Apr 24
Analyst Color, Biotech, Equities, Large Cap, News, Health Care, Price Target, Reiteration, Analyst Ratings, Trading Ideas, General
The Pharmaceutical Industry Finds Itself At A Historical Crossroads
10 Apr 24
News, Penny Stocks, Markets, Trading Ideas
PM Fumio Kishida Urges US Tech Giants To Invest In Japan: 'I'm Strongly Promoting Policies Toward The Next Economic Stage'
10 Apr 24
News, Global, Markets, Tech, General
Pfizer Seeks Expanded Use Of Abrysvo As Vaccine Shows Potential In 18+ Patients
9 Apr 24
Biotech, Large Cap, News, Health Care, Top Stories, General
Decoding Pfizer's Options Activity: What's the Big Picture?
9 Apr 24
Options, Markets
Pfizer Announces Top-Line Results From Phase 3 Study Of ABRYSVO In Adults Aged 18 To 59 At Increased Risk For RSV Disease
9 Apr 24
News, Health Care, General
Amazon, Alphabet And A Pharmaceutical Giant: CNBC's 'Final Trades'
8 Apr 24
Long Ideas, News, Top Stories, Markets, Media, Trading Ideas
Redditors Discuss What The Top 3 Value Stock Picks Are Right Now
5 Apr 24
Long Ideas, Social Media, Opinion, Top Stories, Trading Ideas
Pfizer's Paxlovid Demonstrates Safety But Raises Questions on Efficacy in Low-Risk Covid-19 Patients-NEJM Study
5 Apr 24
Biotech, Large Cap, News, Health Care, General
Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target
5 Apr 24
News, Price Target, Reiteration, Analyst Ratings
10 Health Care Stocks Whale Activity In Today's Session
4 Apr 24
Options
In Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster
4 Apr 24
Biotech, Large Cap, News, Health Care, Legal, General
Press releases
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
11 Apr 24
Press Releases
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
9 Apr 24
Press Releases
ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager
8 Apr 24
Commodities, Small Cap, Press Releases
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
8 Apr 24
Press Releases
Thinking about trading options or stock in NVIDIA, Trump Media & Technology, Microsoft, Enterprise Products Partners, or Pfizer?
1 Apr 24
Opinion, Press Releases
BetterInvesting™ Magazine Update on Paychex Inc. and Pfizer Inc.
28 Mar 24
Opinion, Press Releases
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
20 Mar 24
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
20 Mar 24
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
20 Mar 24
News, Press Releases
European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
13 Mar 24
Press Releases
Thinking about trading options or stock in Apple, Pfizer, Taiwan Semiconductor, Microsoft, or Novo Nordisk?
12 Mar 24
Opinion, Press Releases
Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
12 Mar 24
Press Releases
Thinking about trading options or stock in Advanced Micro Devices, Pfizer, Samsara, New York Community Bancorp, or Walmart?
8 Mar 24
Small Cap, Opinion, Press Releases
ViiV Healthcare Announces Interim Data at CROI Indicating Superior Efficacy of Long-Acting Injectable HIV Treatment Cabenuva (Cabotegravir + Rilpivirine) Compared to Daily Oral Therapy in Individuals Living With HIV Who Have Adherence Challenges
6 Mar 24
Press Releases
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
5 Mar 24
Press Releases
ViiV Healthcare and The American Academy of HIV Medicine Announce Fellowship to Improve HIV Prevention in Key Communities
5 Mar 24
Press Releases
ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses
4 Mar 24
Press Releases
Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
29 Feb 24
Press Releases
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
29 Feb 24
Press Releases
ViiV Healthcare to present data for its next generation of ultra long-acting treatments for HIV
28 Feb 24
Press Releases